EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Allianz SE (ALIZY) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Allianz SE $26.04, price $46.83, upside -44.4%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Financial Services · US · ADR · Home Germany · ISIN US0188201000

AS Allianz SE logo Broad data Sep 28, 2026

Allianz SE

ALIZY · US

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value $26.04 · Strongly overvalued (−44.4%)
✓Quality 67/100
!Mixed Growth (revenue 5y +4.2 %/yr)
✓Solidly profitable · 10.4% net margin (TTM)
✓Moderate debt · generates free cash flow
✓4.4% dividend yield · Sustainable
!Mixed vs. peers (8/15)
!Moderate moat 59/100
!Insider activity 45/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$52.69 $12.87 Fair Value $26.04 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 28, 2026.

How to read this chart

60‑month range $12.87 – $52.69 · fair‑value band $21.38 – $36.92 · the $46.83 price screens above the $26.04 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 28, 2026.

Follow Allianz SE ADR in your weekly email

Every Wednesday you see whether Allianz SE ADR is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide.

Show more

Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide. The company's Property-Casualty segment offers various insurance products, including motor liability, accident, fire and property, general liability, credit, and travel, and assistance services to private and corporate customers. Its Life/Health segment provides a range of life and health insurance products on an individual and a group basis, such as annuities, endowment and term insurance, and unit-linked and investment-oriented products, as well as private and supplemental health, and long-term care insurance products. The company's Asset Management segment offers institutional and retail asset management products and services to third-party investors comprising equity and fixed income funds, cash, and multi-assets; and alternative investment products that include real estate, infrastructure debt/equity, real assets, liquid alternatives, and solutions business. In addition, it provides banking services for retail clients; and digital investment services. Allianz SE was founded in 1890 and is headquartered in Munich, Germany.

Stock analysis

Allianz SE ADR (ALIZY) currently trades at $46.83, while our model-based Fair Value estimate is $26.04, 44.4% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $26.02 per share, and 0 of the 6 models we run sit above the $46.83 price.

Bear case: the Asset-Based group reads lowest at $12.45, and 6 of the 6 models stay below the price. Evidence for this calculation is high.

Scenario range: $21.38 (bear) to $36.92 (bull), the price of $46.83 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 67/100 (solid quality), in the Financial Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Allianz SE ADR reported revenue of €138B in FY2025 versus €119B in FY2021, a compound +3.8%/yr. Reported net income was €10.8B in FY2025, compounding +13.0%/yr from FY2021.

Key figures

Market cap $176B · P/E ratio 13.0 · P/S ratio 1.02 · EPS (TTM) $3.59 · Dividend yield 4.4% · Net margin 7.8% · Return on equity 18.7% · Return on assets (EBIT) 1.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (medium confidence).

What moves the price

The share trades about 11% below its 52-week high and 23% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −22% fair-value upside, at −44%, ALIZY screens richer than that median.

Fair Value models

Bear $21.38 Fair Value $26.04 Bull $36.92
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($2.71 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income $20.42 $24.91 $34.61 76
Gordon GGM $15.48 $22.26 $29.27 69
DDM Multi-Stage $15.48 $21.81 $29.13 67
All 6 models by family
Dividend Discount
Gordon GGM $15.48 $22.26 $29.27 69
DDM Multi-Stage $15.48 $21.81 $29.13 67
Multiples
P/E Multiple $31.14 $41.51 $51.89 63
P/B Multiple $19.52 $26.02 $32.53 55
Asset-Based
NCAV (Graham) $9.29 $12.45 $18.59 54
Economic Profit
Residual Income $20.42 $24.91 $34.61 76

Open the full fair value analysis →

Notify me when ALIZY reaches fair value

Put ALIZY on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 67/100

Of which business quality 57 · Market factors (momentum, volatility) 65

Profitability 30
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 93
Earnings quality: real cash, not paper profit
Fin. Strength 10
Balance sheet, leverage, solvency risk
Investment 92
Disciplined investing over empire-building
Low Volatility 88
Calm price path (market factor)
Momentum 55
Price trend over the last 3–12 months (market factor)
52W Momentum 55
Distance to the 52-week high (market factor)
Net Issuance 100
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 69/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+0.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.2%
Start year 2020 (pandemic). Over 10 years: +2.5% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.4%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+16.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+11.7%
Dividend (yield on the price)4.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11.7% vs 7.0%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 11%
Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +6.9% a year for the forecasts.
Forecast 2026 (sales)+30.4%
Forecast 2027 (sales)+5.0%
Projected 2028 (sales)+4.7%
Projected 2029 (sales)+4.3%
Projected 2030 (sales)+3.9%

ALIZY screens overvalued: fair value 44% below the price. Compare with Zurich Insurance Group →

Earlier news

News mood ⓘNews mood, the average tone of recent news (98 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.

Compare Allianz SE ADR with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Diversified · 81 stocks

Beats the industry median on 7/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 62 · Above median
Fair Value upside −44.8% · Bottom 25%
Profitability
Return on equity (TTM) 18.7% · Above median
Return on assets 1.2% · Below median
Net margin (TTM) 10.4% · Above median
Operating margin (TTM) 19.3% · Top 25%
Growth and dividend
Revenue growth 8.8% · Above median
Dividend yield (TTM) 4.4% · Above median
Balance sheet
Debt / equity 0.52× · Highest 25%

Valuation Multiplesvs Insurance - Diversified median · lower = cheaper

P/E (TTM) 13.0× · Pricier than median
P/B 2.46× · Priciest 25%
P/S (TTM) 1.34× · Pricier than median
P/FCF 5.1× · Cheapest 25%
EV/EBITDA 8.0× · Pricier than median
PEG 2.77× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 8
FUTURE (revenue growth)44 · sector 41
PAST (return on equity)75 · sector 51
HEALTH (low debt)74 · sector 89
DIVIDEND (yield)88 · sector 76

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Allianz SE ALV €412.00 €229.84 −44%
Zurich Insurance Group ZURN CHF 563.60 CHF 328.80 −42%
AXA SA CS €41.90 €36.28 −13%
Assicurazioni Generali S.p.A G €42.75 €10.92 −74%
Sun Life Financial Inc SLF $79.48 $41.03 −48%
American International Group AIG $74.17 $71.58 −3%
Talanx AG TLX €117.40 €91.88 −22%
The Hartford Insurance Group HIG $126.04 $115.03 −9%
Arch Capital Group ACGL $94.26 $127.51 +35%
Swiss Life Holding SLHN CHF 891.00 CHF 413.93 −54%

Explore undervalued stocks

More undervalued Financial Services stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Allianz SE ADR Fair Value". https://www.fairvalue-calculator.com/stock/ALIZY

Frequently asked questions

Is Allianz SE (ALIZY) overvalued or undervalued?
As of Sep 28, 2026, our model estimates a fair value of $26.04 versus a price of $46.83, about −44% upside (overvalued).
What is the fair value of ALIZY?
Our model-based fair value for Allianz SE ADR is $26.04 (as of Sep 28, 2026), built from audited fundamentals. The current price: $46.83.
What is the quality score of ALIZY?
Allianz SE ADR has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Allianz SE (ALIZY)?
Our model-based price target is the fair value of $26.04 (as of Sep 28, 2026) from 6 valuation models. Cautious scenario $21.38, optimistic scenario $36.92. It is a calculation from audited fundamentals, not an analyst target.
What is the Allianz SE ADR stock forecast for 2026?
Our models put fair value at $26.04, about −44% upside versus a price of $46.83 (overvalued). Cautious scenario $21.38, optimistic scenario $36.92. The calculation is refreshed regularly with new filings.
What is the revenue of Allianz SE (ALIZY)?
Allianz SE ADR reported trailing-twelve-month revenue of about €115B (latest available figure, as of Sep 28, 2026).
Does Allianz SE ADR pay a dividend?
Allianz SE ADR currently shows a dividend yield of about 4.39% relative to its recent price (as of Sep 28, 2026).
What growth is priced into Allianz SE (ALIZY)?
For today's price to be fair in a discounted-cash-flow model, Allianz SE ADR would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 8.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.2 % per year. As of Sep 28, 2026.
What discount rate (WACC) does the fair value of ALIZY use?
Our models discount Allianz SE ADR at 8.5 %: a base by market capitalisation (large), damped by beta 0.67, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Allianz SE ADR that is less than minus 40 % per year a year over ten years, using the same discount rate (8.5 %) and the same formula as our fair value.
How much growth has Allianz SE (ALIZY) delivered so far?
Over the past 5 years revenue at Allianz SE ADR grew +4.2 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Allianz SE (ALIZY) growing?
The median revenue growth in the sector is +9.2 % a year. That is the yardstick for the growth priced into Allianz SE ADR (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Allianz SE (ALIZY)?
The free-cash-flow yield on the price is 19.32 %: that much free cash flow Allianz SE ADR produces per unit of market value. When it exceeds the discount rate of our models (8.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Allianz SE (ALIZY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Allianz SE ADR it is $26.04 per share (as of Sep 28, 2026), against a price of $46.83. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Allianz SE ADR stock overvalued or undervalued in 2026?
As of Sep 28, 2026, ALIZY trades above its calculated fair value: price $46.83, fair value $26.04, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALIZY?
No. The price is what the market pays today ($46.83); the fair value is what the company's own numbers justify ($26.04). For Allianz SE ADR the two are $20.79 per share apart. That gap is exactly why we show both numbers side by side.
How much is Allianz SE ADR worth?
The market values Allianz SE ADR at about $176B (market capitalisation, as of Sep 28, 2026). Per share that is $46.83; our models calculate a fair value of $26.04 per share.
What do the bullish and bearish scenarios say about ALIZY?
Our models span a range for Allianz SE ADR: cautious scenario $21.38, base $26.04, optimistic $36.92 per share (as of Sep 28, 2026, price $46.83). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALIZY?
Allianz SE ADR trades at a price-to-earnings ratio of 13.0 (as of Sep 28, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $26.04 is built from several models across several years. Other multiples: PEG 2.8, P/B 2.5, P/S 1.3, EV/EBITDA 8.0.
What is the PEG ratio of ALIZY?
The PEG ratio of Allianz SE ADR is 2.77 (P/E divided by earnings growth, as of Sep 28, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Allianz SE (ALIZY)?
Balance-sheet figures for Allianz SE ADR (as of Sep 28, 2026): return on equity 18.7%, debt of 0.52 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is ALIZY from its 52-week high?
Allianz SE ADR trades at $46.83, about 11% below its 52-week high of $52.69 and 23% above the low of $38.20 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $26.04 is for.
Which stocks are comparable to Allianz SE ADR?
From the same area (Financial Services) we also value Allianz SE, Zurich Insurance Group, AXA SA, Assicurazioni Generali S.p.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Allianz SE ADR stock attractive at the current price?
The data as of Sep 28, 2026: price $46.83, calculated fair value $26.04 (−44%), Quality Score 67/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALIZY calculated?
We run Allianz SE ADR through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $26.04, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Allianz SE ADR itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Allianz SE (ALIZY)?
The closing price on Oct 2, 2026 was $46.83. Our model-based fair value is $26.04, about −44% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Allianz SE ADR right now?
The price sits above even our optimistic bull case ($36.92). The favourable scenario is already priced in. Solid but not exceptional quality (67/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Allianz SE (ALIZY) come from?
Earnings per share at Allianz SE ADR grew +6.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share +4.4 %, EBIT margin +1.2 %, tax rate +0.7 %, residual (interest, one-offs) +0.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Allianz SE ADR

How large is the market capitalisation of Allianz SE (ALIZY)?
The market capitalisation of Allianz SE ADR is $176B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Allianz SE (ALIZY)?
The price-to-sales ratio of Allianz SE ADR is 1.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Allianz SE (ALIZY)?
Earnings per share at Allianz SE ADR are $3.59 (price ÷ EPS = P/E 13.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Allianz SE (ALIZY)?
The dividend yield of Allianz SE ADR is 4.4% (payout 57.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Allianz SE (ALIZY)?
The net margin of Allianz SE ADR is 7.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Allianz SE (ALIZY)?
The return on equity (ROE) of Allianz SE ADR is 18.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Allianz SE (ALIZY)?
On an EBIT basis the return on assets of Allianz SE ADR is 1.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Allianz SE (ALIZY)?
The operating margin of Allianz SE ADR is 19.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Allianz SE (ALIZY)?
Revenue at Allianz SE ADR is growing +8.8% versus a year earlier (3y avg +19.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Allianz SE (ALIZY)?
Earnings per share at Allianz SE ADR are growing +52.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Allianz SE (ALIZY) carry?
The net debt of Allianz SE ADR is €5.4B (fiscal year 2025, ≈ 0.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Allianz SE ADR in the live analysis

One click puts Allianz SE ADR on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.